Zum Hauptinhalt springen
| Hans-Günter Meyer-Thompson | Buprenorphin

Frontline Science: Buprenorphine decreases CCL2-mediated migration of CD14+ CD16+ monocytes.

Frontline Science: Buprenorphine decreases CCL2-mediated migration of CD14+ CD16+ monocytes.

Jaureguiberry-Bravo M, Lopez L, Berman JW.

J Leukoc Biol. 2018 May 23. doi: 10.1002/JLB.3HI0118-015R. 

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/29791013